ASM8

DRUG3 trials

Sponsors

Syntara

Conditions

Asthma

Phase 1

Multiple Dose ASM8 in Mild Asthmatics

CompletedNCT00264966

Start: 2005-12-31End: 2006-04-30Target: 15Updated: 2012-12-03

Phase 2

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

TerminatedNCT00402948

Start: 2007-02-28End: 2007-12-31Updated: 2012-12-03

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

WithdrawnNCT01380236

Start: 2011-11-30End: 2013-05-31Updated: 2012-12-03